Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus

Clinical trial NCT00003076 · COMPLETED

Trial details

NCT number: NCT00003076
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 1995-10-01
Primary completion: 2002-06-01
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.